Riskpilot← Back to searchSign inGet full accessMEDIDYNE A/S
A/SActiveCVR 26925398Skodsborgvej 311Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200254 employees
Revenue 2025
DKK 53,5M
+20% vs 2024
EBITDA margin
25.1%
+2% vs 2024
Equity ratio
51.9%
Financial strength
Net profit 2025
DKK 11M
-5% vs 2024
| Revenue | DKK 53,5M | +20% |
| EBITDA | DKK 13,4M | +2% |
| Net profit | DKK 11M | -5% |
| Total assets | DKK 104,7M | +4% |
| Equity | DKK 54,4M | +26% |
| Employees | 54 | — |
Legal name
MEDIDYNE A/S
CVR number
26925398
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. december 2002
Share capital
DKK 1.000.000
Employees
54 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand, den samlede bestyrelse eller af en direktør.
Company purpose
Selskabets formål er at drive handel og anden dermed beslægtet virksomhed.
Address
Skodsborgvej 311
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12.528 | 14.595 | 19.542 | 22.299 | 12.265 | 19.931 | 16.997 | 26.622 | 35.124 | 54.205 | 53.373 | 38.473 | 44.407 | 53.462 |
| Staff expenses | -7.651 | -10.440 | -13.427 | -17.866 | -9.726 | -15.678 | -14.162 | -17.271 | -22.692 | -23.118 | -33.354 | -27.136 | -31.248 | -40.029 |
| EBITDA | 4.877 | 4.190 | 6.465 | 4.382 | 2.569 | 4.308 | 2.742 | 4.151 | 12.277 | 30.266 | 20.019 | 11.338 | 13.159 | 13.432 |
| Depreciation & amort. | 702 | -594 | -730 | -862 | -425 | -412 | -495 | -360 | -590 | -750 | -766 | -812 | -922 | -683 |
| EBIT | 4.175 | 3.596 | 5.735 | 3.520 | 2.144 | 3.896 | 2.247 | 3.791 | 11.687 | 29.516 | 19.253 | 10.525 | 12.237 | 12.749 |
| Net financials | 139 | 797 | 2.196 | 321 | 491 | 5.215 | 3.192 | 556 | -487 | 1.809 | 264 | -23 | 2.095 | 1.194 |
| Profit before tax | 4.313 | 4.436 | 7.931 | 3.959 | 2.635 | 9.110 | 5.439 | 4.346 | 11.200 | 31.325 | 19.517 | 11.159 | 14.886 | 14.120 |
| Tax | 980 | 850 | 1.613 | 920 | 389 | 1.238 | 731 | 2.353 | 2.390 | 7.079 | 4.324 | 2.487 | 3.305 | 3.142 |
| Net profit | 3.334 | 3.586 | 6.318 | 3.039 | 2.246 | 7.872 | 4.708 | 1.993 | 8.809 | 24.246 | 15.193 | 8.672 | 11.580 | 10.977 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 22.357 | 28.445 | 38.641 | 41.940 | 41.578 | 54.702 | 77.708 | 56.238 | 74.803 | 95.586 | 85.577 | 106.601 | 100.395 | 104.709 |
| Equity | 9.141 | 9.728 | 13.045 | 20.738 | 22.899 | 29.112 | 22.018 | 24.598 | 33.434 | 48.224 | 42.058 | 34.277 | 43.201 | 54.392 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 951 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13.216 | 18.717 | 25.595 | 21.202 | 18.679 | 25.591 | 55.690 | 31.578 | 40.403 | 47.363 | 43.519 | 72.323 | 57.194 | 50.317 |
| Total debt | 13.216 | 18.717 | 25.595 | 21.202 | 18.679 | 25.591 | 55.690 | 31.578 | 41.355 | 47.363 | 43.519 | 72.323 | 57.194 | 50.317 |
EBITDA margin
25.1%
This company
15.8%
Market median
+59% vs market
20122025
Equity ratio
51.9%
This company
38.2%
Market median
+36% vs market
20122025
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20122025
Net profit margin
20.5%
This company
8.1%
Market median
+153% vs market
20122025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20122025
Debt / equity
0.93×
This company
0.62×
Market median
+50% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
- Annual report 2020Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
- Annual report 2019Filed via CVR / Virk · Period 2018-04-01 – 2019-03-31
- Annual report 2018Filed via CVR / Virk · Period 2017-04-01 – 2018-03-31
- Annual report 2017Filed via CVR / Virk · Period 2016-04-01 – 2017-03-31
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-03-31
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KW Management | Management | 2002 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairman | 2015 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HJERTEVAGT HOLDING ApS | Company | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KWC Holding ApS
MEDIDYNE A/S Board members of MEDIDYNE A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Werring Clem | Management | 0 companies |
| Søren Stenkilsson | Board of Directors | 0 companies |
| Frederik Werring Clem | Chairman | 0 companies |